The TIDE study is currently recruiting participants.
The Province of Ontario Neurodevelopmental Network (POND) is conducting new research to understand how genes affect the brain and behaviour in Autism Spectrum Disorder (ASD). We are looking for children ages 12 to 18 to take part in trials of new medications to treat the core symptoms of ASD.
Doctors at Hamilton Health Sciences and McMaster University are studying a new medication (tideglusib) for the treatment of children and adolescents with Autism Spectrum Disorder (ASD). Participation will require approximately 9 visits to Hamilton Health Sciences and McMaster University over a 4 month period. Most visits will take about two hours. Questionnaires about symptoms and side effects will be completed at each visit. Including the screening visit, blood samples will be required at 6 of the visits in order to monitor safety. Medication will be provided at no cost during the study, and expenses related to participation (such as parking) will be paid for by the research team. Participants will also receive a gift card at each visit as a token of appreciation for their time and effort.
If you (or your child) are between the ages of 12 and 17, have ASD, and want to learn more about this study, contact Alessia Greco at 905-525-9140 x 21261 or by e-mail at email@example.com. Contacting us does not obligate you or your child to participate in the study.